benzoxazoles has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 14 (60.87) | 29.6817 |
2010's | 7 (30.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drummond, RM; Petrou, S; Singer, JJ; Ugur, M; Walsh, JV | 1 |
Chessell, IP; Hibell, AD; Humphrey, PP; Michel, AD; Simon, J | 1 |
Chessell, IP; Hibell, AD; Humphrey, PP; Kidd, EJ; Michel, AD | 1 |
Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD | 1 |
Hibell, AD; Humphrey, PP; Michel, AD; Thompson, KM; Xing, M | 1 |
Kunze, DL; Ramirez, AN | 1 |
Kawamura, H; Kobayashi, M; Kobayshi, M; Li, Q; Puro, DG; Sugiyama, T | 1 |
Brosnan, CF; Lee, SC; Narcisse, L; Scemes, E; Zhao, Y | 1 |
Alcaraz, L; Bent, J; Bowers, K; Braddock, M; Fagura, M; Furber, M; Jiang, LH; Laurent, C; Lawson, M; Mortimore, M; Stokes, L; Surprenant, A; Theaker, J | 1 |
Barletta, RG; Czuprynski, CJ; Woo, SR | 1 |
Chou, YC; Huang, WC; Lee, WL; Lo, JC; Sun, SH; Tseng, CH | 1 |
Boyd, J; Denlinger, LC; Guadarrama, A; Korpi-Steiner, NL; Puffer, EB; Schell, K; Sheerar, D; Urben, C | 1 |
Baudouin, C; Brignole-Baudouin, F; Dutot, M; Liang, H; Pauloin, T; Rat, P; Warnet, JM | 1 |
Carroll, WA; Donnelly-Roberts, DL; Jarvis, MF; Namovic, MT; Perez-Medrano, A; Surber, B; Vaidyanathan, SX; Wang, Y | 1 |
An, D; Chen, J; He, B; Li, M; Liu, P; Meng, L; Zhang, X; Zhang, Y; Zhao, J | 1 |
Fang, KM; Sun, SH; Tzeng, SF; Yang, CS | 1 |
Chen, MC; Liu, YP; Sun, SH; Tzeng, SF; Yang, CS | 1 |
Bradley, HJ; Browne, LE; Jiang, LH; Yang, W | 1 |
Chaumont, S; Chemin, J; Compan, V; Rassendren, F; Stelmashenko, O; Ulmann, L | 1 |
Austin, JS; Beggs, S; Costigan, M; Diatchenko, L; Dorfman, R; Gershon, E; Herbert, TA; John, SL; Jordan, J; Livneh, J; Maixner, W; Mogil, JS; Peltz, G; Ritchie, J; Salter, MW; Seltzer, Z; Slade, GD; Smith, SB; Sorge, RE; Tan, K; Tichauer, D; Trang, T; Vander Meulen, H; Woolf, CJ; Yarkoni-Abitbul, M; Zaykin, DV; Zheng, M | 1 |
Franke, H; Grohmann, M; Illes, P; Kunert, C; Messemer, N; Nieber, K; Nörenberg, W; Riedel, T; Rubini, P; Schaefer, M; Sobottka, H; Straub, I; Zimmermann, H | 1 |
Ebert, P; Fijal, B; Grubisha, O; Langron, E; McNearney, TA; Merchant, K; Mogg, A; Munsie, L; Qian, YW; Ruble, C; Sher, E; Ursu, D; Zou, W | 1 |
Bowyer, SL; Kassiou, M; O'Brien-Brown, J; Reekie, TA; Werry, EL; Wong, ECN | 1 |
23 other study(ies) available for benzoxazoles and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Article | Year |
---|---|
P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Cell Membrane Permeability; Electrophysiology; Fluorescent Dyes; Gene Expression; Ion Channels; Meglumine; Microinjections; Oocytes; Patch-Clamp Techniques; Phenotype; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Proteins; RNA, Complementary; Xenopus | 1997 |
Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Benzoxazoles; Calcium; Calcium Radioisotopes; CHO Cells; Cricetinae; DNA, Complementary; Electrophysiology; Fluorescent Dyes; Gene Amplification; Membrane Potentials; Purinergic P2 Receptor Agonists; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical | 1998 |
Apparent species differences in the kinetic properties of P2X(7) receptors.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Benzoxazoles; Cell Line; Fluorescent Dyes; Food Additives; Humans; Mice; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Signal Transduction; Sodium Chloride; Sodium Glutamate; Species Specificity | 2000 |
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical | 2000 |
Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amiloride; Animals; Benzoxazoles; Buffers; Cations, Divalent; Cell Adhesion; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Ethidium; Fluorescent Dyes; Humans; Kinetics; Mice; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Serum Albumin, Bovine; Sodium Chloride; Species Specificity; Temperature | 2001 |
P2X purinergic receptor channel expression and function in bovine aortic endothelium.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzoxazoles; Blotting, Western; Brain Chemistry; Cattle; Cerebellum; Electric Conductivity; Electrophysiology; Endothelium, Vascular; Fluorescent Dyes; Gene Expression; Hippocampus; Humans; Immunohistochemistry; Membrane Potentials; Nodose Ganglion; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X4; Receptors, Purinergic P2X5; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin; Thionucleotides | 2002 |
Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Benzoxazoles; Cell Membrane Permeability; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electrophysiology; Endothelium, Vascular; Fluorescent Dyes; Immunoenzyme Techniques; In Situ Nick-End Labeling; Ion Channels; Pericytes; Quinolinium Compounds; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Retinal Vessels | 2004 |
The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
Topics: Adenosine Triphosphate; Astrocytes; Benzoxazoles; Calcium Signaling; Cell Membrane; Cells, Cultured; Encephalitis; Fluorescent Dyes; Humans; Interleukin-1; Multiple Sclerosis; Nitric Oxide; Protein Transport; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; Signal Transduction; Up-Regulation | 2005 |
Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.
Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Anti-Inflammatory Agents; Benzoxazoles; Calcium Signaling; Cell Line; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Imides; Interleukin-1beta; Ion Channel Gating; Lipopolysaccharides; Membrane Potentials; Monocytes; Patch-Clamp Techniques; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Species Specificity; Thiazoles; Transfection; Xanthenes | 2006 |
Extracellular ATP is cytotoxic to mononuclear phagocytes but does not induce killing of intracellular Mycobacterium avium subsp. paratuberculosis.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Caspase 3; Cattle; Cell Line; Cells, Cultured; Lactate Dehydrogenases; Macrophages; Mice; Monocytes; Mycobacterium avium; Phagocytes; Quinolinium Compounds | 2007 |
Activation of P2X(7) receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms.
Topics: Adenosine Triphosphate; Amino Acid Transport System X-AG; Animals; Animals, Newborn; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Cerebral Cortex; Drug Interactions; Enzyme Inhibitors; Glutamate-Ammonia Ligase; Glutamic Acid; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 2008 |
Standardized method to minimize variability in a functional P2X(7) flow cytometric assay for a multi-center clinical trial.
Topics: Adenosine Triphosphate; Aging; Asthma; Benzoxazoles; Cell Survival; Clinical Trials as Topic; Flow Cytometry; Fluorescence; Humans; Lipopolysaccharide Receptors; Monocytes; Multicenter Studies as Topic; Phlebotomy; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 2008 |
Effects of toxic cellular stresses and divalent cations on the human P2X7 cell death receptor.
Topics: Adenosine Triphosphate; Adolescent; Adult; Benzalkonium Compounds; Benzoxazoles; Cations, Divalent; Cell Death; Cell Line; Conjunctiva; Epithelium, Corneal; Eye; Humans; Iatrogenic Disease; Lens, Crystalline; Oxidative Stress; Pigment Epithelium of Eye; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 2008 |
[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
Topics: Adenosine Triphosphate; Animals; Astrocytoma; Benzoxazoles; Binding, Competitive; Calcium; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Drug; Guanidines; Humans; Inhibitory Concentration 50; Interleukin-1beta; Mice; Purinergic P2 Receptor Antagonists; Quinolines; Quinolinium Compounds; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Proteins; Transfection; Tritium | 2009 |
The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Apoptosis; Benzoxazoles; Biological Transport; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Leukemia; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Spectrometry, Fluorescence; Time Factors | 2009 |
Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.
Topics: Actins; Adenosine Triphosphate; Animals; Animals, Newborn; Benzoxazoles; Calcium; Cells, Cultured; Cerebral Cortex; Cyclophilin A; Dose-Response Relationship, Drug; Flow Cytometry; Microglia; Phagocytosis; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X2; RNA, Messenger; Time Factors; Transduction, Genetic | 2009 |
Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Transporter 1; Female; Gene Expression Regulation; Glutamic Acid; Humans; Injections, Spinal; Neurons; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spinal Cord Injuries; Transfection | 2010 |
Pharmacological properties of the rhesus macaque monkey P2X7 receptor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amino Acid Sequence; Animals; Benzoxazoles; HEK293 Cells; Humans; Macaca mulatta; Membrane Potentials; Molecular Sequence Data; Patch-Clamp Techniques; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Quinolinium Compounds; Receptors, Purinergic P2X7; Single-Cell Analysis; Tetrazoles; Thiazoles | 2011 |
P2X2 and P2X5 subunits define a new heteromeric receptor with P2X7-like properties.
Topics: Adenosine Triphosphate; Animals; Annexin A5; Benzoxazoles; Bioluminescence Resonance Energy Transfer Techniques; Brain; Enzyme-Linked Immunosorbent Assay; Ganglia, Spinal; HEK293 Cells; Humans; Immunoprecipitation; Luminescent Proteins; Membrane Potentials; Mice; Mutagenesis, Site-Directed; Mutation; Patch-Clamp Techniques; Protein Subunits; Purinergic Agents; Quinolinium Compounds; Receptors, Purinergic P2X2; Receptors, Purinergic P2X5; Receptors, Purinergic P2X7; Transfection; Video Recording; Xenopus laevis | 2012 |
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Carbenoxolone; Cells, Cultured; Chronic Pain; Cohort Studies; Connexins; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Linkage; Genome-Wide Association Study; Genotype; Histidine; Humans; Hyperalgesia; Macrophages; Male; Mastectomy; Mice; Mice, Inbred Strains; Mutation; Nerve Tissue Proteins; Osteoarthritis; Pain Measurement; Pain Threshold; Peptides; Polymorphism, Single Nucleotide; Quinolinium Compounds; Receptors, Purinergic P2X7; Retrospective Studies; Species Specificity; Time Factors; Transfection | 2012 |
P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Caspase 3; Cell Survival; Dose-Response Relationship, Drug; Lateral Ventricles; Membrane Potentials; Mice; Mice, Knockout; Primary Cell Culture; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Rosaniline Dyes; Stem Cells; Tetrazoles | 2013 |
Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.
Topics: Adenosine Triphosphate; Analysis of Variance; Benzoxazoles; Calcium; Diabetic Neuropathies; Female; Gene Expression Regulation; Genotype; HEK293 Cells; Humans; Male; Middle Aged; Pain Measurement; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Purinergic P2X Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2X7; Transfection | 2014 |
Pharmacological evaluation of a novel series of urea, thiourea and guanidine derivatives as P2X
Topics: Adamantane; Adenosine Triphosphate; Benzoxazoles; Cell Line; Fluorescent Dyes; Guanidines; Humans; Molecular Structure; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Quinolinium Compounds; Thiourea; Urea | 2017 |